deltatrials
Completed PHASE2 INTERVENTIONAL 5-arm NCT04566601

A Study to Test Different Doses of BI 1358894 and Find Out Whether They Reduce Symptoms in People With Borderline Personality Disorder

A Phase II Randomized, Double-blinded, Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of 4 Oral Doses of BI 1358894 Once Daily Over 12 Week Treatment Period in Patients With Borderline Personality Disorder

Sponsor: Boehringer Ingelheim

Conditions Borderline Personality Disorder
Interventions BI 1358894 Placebo
Updated 31 times since 2020 Last updated: Jan 22, 2024 Started: Nov 13, 2020 Primary completion: Dec 9, 2022 Completion: Jan 25, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Borderline Personality Disorder, this trial is completed. The trial is conducted by Boehringer Ingelheim and has accumulated 31 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Oct 2020 – ~Nov 2020 · 31 days · monthly snapshot~Nov 2020 – ~Dec 2020 · 30 days · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Mar 2021 · 28 days · monthly snapshot~Mar 2021 – ~Apr 2021 · 31 days · monthly snapshot~Apr 2021 – ~May 2021 · 30 days · monthly snapshot~May 2021 – ~Jun 2021 · 31 days · monthly snapshot~Jun 2021 – ~Sep 2021 · 3 months · monthly snapshot~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshot~Oct 2021 – ~Nov 2021 · 31 days · monthly snapshot~Nov 2021 – ~Dec 2021 · 30 days · monthly snapshot~Dec 2021 – ~Jan 2022 · 31 days · monthly snapshot~Jan 2022 – ~Feb 2022 · 31 days · monthly snapshot~Feb 2022 – ~Mar 2022 · 28 days · monthly snapshot~Mar 2022 – ~Apr 2022 · 31 days · monthly snapshot~Apr 2022 – ~May 2022 · 30 days · monthly snapshot~May 2022 – ~Jun 2022 · 31 days · monthly snapshot~Jun 2022 – ~Jul 2022 · 30 days · monthly snapshot~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshot~Sep 2022 – ~Nov 2022 · 2 months · monthly snapshot~Nov 2022 – ~Dec 2022 · 30 days · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Feb 2023 · 31 days · monthly snapshot~Feb 2023 – ~Mar 2023 · 28 days · monthly snapshot~Mar 2023 – ~Sep 2023 · 6 months · monthly snapshot~Sep 2023 – ~Feb 2024 · 5 months · monthly snapshot~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

31 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Feb 2024 — Jul 2024 [monthly]

    Completed PHASE2

  5. Sep 2023 — Feb 2024 [monthly]

    Completed PHASE2

▶ Show 26 earlier versions

  1. Mar 2023 — Sep 2023 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  2. Feb 2023 — Mar 2023 [monthly]

    Active Not Recruiting PHASE2

  3. Jan 2023 — Feb 2023 [monthly]

    Active Not Recruiting PHASE2

  4. Dec 2022 — Jan 2023 [monthly]

    Active Not Recruiting PHASE2

  5. Nov 2022 — Dec 2022 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  6. Sep 2022 — Nov 2022 [monthly]

    Recruiting PHASE2

  7. Jul 2022 — Sep 2022 [monthly]

    Recruiting PHASE2

  8. Jun 2022 — Jul 2022 [monthly]

    Recruiting PHASE2

  9. May 2022 — Jun 2022 [monthly]

    Recruiting PHASE2

  10. Apr 2022 — May 2022 [monthly]

    Recruiting PHASE2

  11. Mar 2022 — Apr 2022 [monthly]

    Recruiting PHASE2

  12. Feb 2022 — Mar 2022 [monthly]

    Recruiting PHASE2

  13. Jan 2022 — Feb 2022 [monthly]

    Recruiting PHASE2

  14. Dec 2021 — Jan 2022 [monthly]

    Recruiting PHASE2

  15. Nov 2021 — Dec 2021 [monthly]

    Recruiting PHASE2

  16. Oct 2021 — Nov 2021 [monthly]

    Recruiting PHASE2

  17. Sep 2021 — Oct 2021 [monthly]

    Recruiting PHASE2

  18. Jun 2021 — Sep 2021 [monthly]

    Recruiting PHASE2

  19. May 2021 — Jun 2021 [monthly]

    Recruiting PHASE2

  20. Apr 2021 — May 2021 [monthly]

    Recruiting PHASE2

  21. Mar 2021 — Apr 2021 [monthly]

    Recruiting PHASE2

  22. Feb 2021 — Mar 2021 [monthly]

    Recruiting PHASE2

  23. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE2

  24. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  25. Nov 2020 — Dec 2020 [monthly]

    Not Yet Recruiting PHASE2

  26. Oct 2020 — Nov 2020 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Boehringer Ingelheim
Data source: Boehringer Ingelheim

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aachen, Germany , Aalborg, Denmark , Alpharetta, United States , Anaheim, United States , Belmont, United States , Berlin, Germany , Bialystok, Poland , Bonn, Germany , Brescia, Italy , Bron, France and 49 more locations